Improving affectability of fluid biopsy utilizing ‘inexactly stacked’ identification layers Kumar Jeetendra | November 4, 2020 By detecting DNA fragments in body fluids like urine, some kinds of cancer may already be tracked in an early stage. But in order to capture them, detection sensitivity must be improved. Researchers at the University of Twente in The Netherlands (MESA+ Institute) use electrically charged polymers for this. Not only one layer of this, …
Blood vessel deformities start in vein cells Kumar Jeetendra | November 3, 2020 In the condition called cavernoma, lesions appear in a cluster of blood vessels in the brain, spinal cord or retina. Researchers from Uppsala University can now reveal, at molecular level, these changes originate in vein cells. This new understanding of the condition creates possibility of developing better treatments for patients. The study was published in …
South African firm Aspen Pharmacare and Johnson and Johnson strike immunization bargain Kumar Jeetendra | November 3, 2020 South African pharmaceutical company Aspen Pharmacare has announced a deal with U.S. firm Johnson & Johnson to manufacture its COVID-19 vaccine candidate, if it’s accepted in South Africa and internationally. In a statement issued on Monday, Aspen said that if ongoing trials bring global health authorities to endorse the J&J vaccine as safe and effective, …
Washing hands and Halloween candy can diminish COVID-19 introduction hazard Kumar Jeetendra | November 2, 2020 New research indicates that COVID-19 exposure risk from contaminated candy might be successfully mitigated either by washing hands and washing candy with a simple at-home technique. A group of researchers published this work today in mSystems, an open-access journal of the American Society for Microbiology. The researchers enrolled 10 recently diagnosed asymptomatic or mildly/moderately symptomatic …
CureVac’s COVID-19 antibody triggers invulnerable reaction in Phase I preliminary Kumar Jeetendra | November 2, 2020 CureVac’s experimental COVID-19 vaccine triggered an immune response in humans, it said on Monday, placing the German biotech firm on track to start mass testing this year since the race to end the pandemic heats up. “We are very encouraged by the interim Phase I data,” Chief Executive Officer Franz-Werner Haas said in a statement, …
Drug used to control pulse may improve malignant growth patients’ reaction to immunotherapy Kumar Jeetendra | November 1, 2020 The exact same biochemical triggers which spur a”flight or fight” reaction once we encounter threats may help tumor cells to thrive. A group of researchers from Roswell Park Comprehensive Cancer Center is looking at ways to interrupt that dynamic so that cancer therapies can be effective. Their latest work, published today in Clinical Cancer Research, …
Bharat Biotech to dispatch Covaxin in Q2 2021 Kumar Jeetendra | November 1, 2020 Bharat Biotech is planning to establish its own vaccine for COVID-19 in the second quarter next year when it will get the requisite approvals in the Indian regulatory authorities, a top company official said. It stated its immediate focus is to conduct the Phase 3 trials across websites in the nation. The company’s vaccine candidate …
SARS-CoV-2 hereditary changes may have made COVID-19 more infectious Kumar Jeetendra | October 31, 2020 A study involving over 5,000 COVID-19 patients in Houston finds the virus which causes the disease is accumulating genetic mutations, one of which may have made it longer infectious. According to the paper published in the peer reviewed journal mBIO, that mutation, known as D614G, is found in the spike protein that pries open our …
HCG- The Specialist in Cancer Care in Collaboration with Pinkathon organized an awareness session on Women’s Health & Breast Cancer Kumar Jeetendra | October 30, 2020 Bangalore, 29th October 2020: To mark Breast Cancer awareness month observed in October, HCG-The Specialist in Cancer care in association with Pinkathon hosted The Pink Strong Talks, a virtual live session to create awareness on ‘women’s health and breast cancer’. The speakers for the session were Dr. BS Ajaikumar, Chairman & CEO, Healthcare Global Enterprise …
Cell scientists and bioimaging master collaborate to settle fourth measurement insider facts Kumar Jeetendra | October 29, 2020 Cell biologists at the University of Illinois in Urbana-Champaign and Bar-Ilan University in Israel and a bioimaging expert at the University of Central Florida are teaming up in what they expect may result in a major breakthrough in the understanding of the three-dimensional organization of the nucleus over their role in certain diseases. The dream …
First arrangement of COVID-19 antibodies liable to be ‘defective’, cautions UK master Kumar Jeetendra | October 29, 2020 The first set of COVID-19 vaccines that clear clinical trials for rollout to combat the deadly virus are most likely to be imperfect and might not work equally for everyone, the chief of the United Kingdom government’s Vaccine Taskforce has warned. Kate Bingham, Chair of the UK’s Vaccine Taskforce set up earlier this year to …
Next harvest of COVID-19 immunization designers take more customary route Kumar Jeetendra | October 29, 2020 The handful of drugmakers dominating the global coronavirus vaccine race are pushing the bounds of vaccine technology. The following crop under development feature more traditional, proven designs. The world will need several different vaccines to fight the COVID-19 pandemic, given the sheer size of international need, variations in effects on various populations, and possible limits …
